Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and peripheral blood mononuclear cells

被引：0
|
作者：
Voortman, J. [1 ]
Ceresa, C. [2 ]
Giovannetti, E. [1 ]
Laan, A. C. [1 ]
Honeywell, R. [1 ]
Giaccone, G. [3 ]
Peters, G. J. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Univ Milano Bicocca, Monza, Italy
[3] NCI, Bethesda, MD 20892 USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells
    Ceresa, Cecilia
    Giovannetti, Elisa
    Voortman, Jens
    Laan, Adrie C.
    Honeywell, Richard
    Giaccone, Giuseppe
    Peters, Godefridus J.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (05) : 1026 - 1036
  • [2] Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cells
    Li, Tianhong
    Ling, Yi-He
    Goldman, I. David
    Perez-Soler, Roman
    CLINICAL CANCER RESEARCH, 2007, 13 (11) : 3413 - 3422
  • [3] Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours
    van Moorsel, CJA
    Pinedo, HM
    Smid, K
    Comijn, EM
    Voorn, DA
    Veerman, G
    Lakerveld, B
    Van der Vijgh, WJF
    Giaccone, G
    Postmus, PE
    Peters, GJ
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) : 2420 - 2429
  • [4] Schedule-dependent synergistic effect of pemetrexed combined with gemcitabine against malignant pleural mesothelioma and non-small cell lung cancer cell lines
    Naga, Shinjiro
    Takenaka, Kazumasa
    Sonobe, Makoto
    Wada, Hiromi
    Tanaka, Fumihiro
    CHEMOTHERAPY, 2008, 54 (03) : 166 - 175
  • [5] Schedule-dependent cytotoxicity of sunitinib and TRAIL in human non-small cell lung cancer cells with or without EGFR and KRAS mutations
    Bao, Yong-Xia
    Zhao, Xiao-Dan
    Deng, Hong-Bin
    Lu, Chang-Lian
    Guo, Yang
    Lu, Xing
    Deng, Li-Li
    CELLULAR ONCOLOGY, 2016, 39 (04) : 343 - 352
  • [6] Schedule-dependent cytotoxicity of sunitinib and TRAIL in human non-small cell lung cancer cells with or without EGFR and KRAS mutations
    Yong-Xia Bao
    Xiao-Dan Zhao
    Hong-Bin Deng
    Chang-Lian Lu
    Yang Guo
    Xing Lu
    Li-Li Deng
    Cellular Oncology, 2016, 39 : 343 - 352
  • [7] Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung cancer cell lines
    Piperdi, Bilal
    Ling, Yi-He
    Perez-Soler, Roman
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : 715 - 721
  • [8] Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer
    Matsumoto, S
    Igishi, T
    Hashimoto, K
    Kodani, M
    Shigeoka, Y
    Nakanishi, H
    Touge, H
    Kurai, J
    Makino, H
    Takeda, K
    Yasuda, K
    Hitsuda, Y
    Shimizu, E
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (05) : 1311 - 1318
  • [9] A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer
    López-Vivanco, G
    Fuente, N
    Barceló, R
    Rubio, I
    Muñoz, A
    Mañé, JM
    Pérez-Hoyos, T
    Viteri, A
    Ferreiro, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2003, 23 (01) : 9 - 16
  • [10] A pilot study on pyroptosis related genes in peripheral blood mononuclear cells of non-small cell lung cancer patients
    Ruoyu Song
    Yongbin Wu
    Shijun He
    Wanxin Chen
    Huan Chen
    Qianlu Wang
    Shouman Wang
    Lan Xiao
    Sichuang Tan
    Sipin Tan
    BMC Pulmonary Medicine, 23
12345